| Title | Purinergic Signalling |
| Abbreviation | Purinergic Signal. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Molecular Biology (Q2); Cell Biology (Q3); Cellular and Molecular Neuroscience (Q3) |
| h-index | 70 |
| Overall Rank/Ranking | 6495 |
| SCImago Journal Rank (SJR) | 0.825 |
| Impact Score | 2.92 |
| Publisher | Springer Science and Business Media B.V. |
| Country | Netherlands |
| ISSN | 15739538, 15739546 |
| Best Quartile | Q2 |
| Coverage History | 2004-2025 |
Purinergic Signalling is a new journal launched in response to rapidly growing interest in purinergic signalling, with its exceptionally wide spectrum of signalling functions in health and disease. Coverage includes original articles, reviews, hot topics and controversies, and meeting reports.
There is both short-term purinergic signalling in transmission and secretion and long-term (trophic) signalling in controlling cell proliferation, differentiation, motility and death in development and regeneration and there is increasing interest in the roles of purines and pyrimidines in pathophysiological conditions and their therapeutic potential in disease.
Purinergic Signalling is a journal covering the technologies/fields/categories related to Molecular Biology (Q2); Cell Biology (Q3); Cellular and Molecular Neuroscience (Q3). It is published by Springer Science and Business Media B.V.. The overall rank of Purinergic Signalling is 6495. According to SCImago Journal Rank (SJR), this journal is ranked 0.825. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 70. The best quartile for this journal is Q2.
The ISSN of Purinergic Signalling journal is 15739538, 15739546. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Purinergic Signalling is cited by a total of 495 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Purinergic Signalling is 2.92, which is computed in 2025 as per its definition. Purinergic Signalling IF is increased by a factor of 0.33 and approximate percentage change is 12.74% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Purinergic Signalling is 2.92. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.92 |
| 2023 | 2.59 |
| 2022 | 2.66 |
| 2021 | 3.27 |
| 2020 | 3.17 |
| 2019 | 2.80 |
| 2018 | 3.13 |
| 2017 | 3.41 |
| 2016 | 3.01 |
| 2015 | 3.30 |
| 2014 | 3.59 |
Purinergic Signalling has an h-index of 70. It means 70 articles of this journal have more than 70 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Purinergic Signalling is 15739538, 15739546. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Purinergic Signalling is 6495. According to SCImago Journal Rank (SJR), this journal is ranked 0.825. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.825 |
| 2023 | 0.797 |
| 2022 | 0.755 |
| 2021 | 0.738 |
| 2020 | 1.064 |
| 2019 | 1.086 |
| 2018 | 1.010 |
| 2017 | 1.104 |
| 2016 | 1.358 |
| 2015 | 1.522 |
| 2014 | 1.893 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 6495 |
| 2023 | 6260 |
| 2022 | 6461 |
| 2021 | 6385 |
| 2020 | 3984 |
| 2019 | 3806 |
| 2018 | 4308 |
| 2017 | 3822 |
| 2016 | 2792 |
| 2015 | 2317 |
| 2014 | 1546 |
Purinergic Signalling is published by Springer Science and Business Media B.V.. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2004-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Purinergic Signalling is Purinergic Signal.. This abbreviation ('Purinergic Signal.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Molecular Biology (Q2); Cell Biology (Q3); Cellular and Molecular Neuroscience (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Purinergic Signalling latest impact IF is 2.92. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.59 (2014) and 2.59 (2023), respectively, in the last 11 years. Moreover, its average IS is 3.08 in the previous 11 years.
The Purinergic Signalling has an SJR (SCImago Journal Rank) of 0.825, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.893 in 2014 and the lowest being 0.738 in 2021. Furthermore, the average SJR of the Purinergic Signalling over the previous 11-year period stands at 3.08.
The latest h-index of the Purinergic Signalling is 70.
The Purinergic Signalling is published by the Springer Science and Business Media B.V., with its country of publication being the Netherlands.
The Purinergic Signalling is currently ranked 6495 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1546 in 2014 and its lowest position of 6495 in 2024.
The standard ISO4 abbreviation for the Purinergic Signalling is Purinergic Signal..
Purinergic Signalling is classified as a journal that the Springer Science and Business Media B.V. publishes.
The Purinergic Signalling encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Purinergic Signalling is assigned the following International Standard Serial Numbers (ISSN): 15739538, 15739546.
The best quartile for the Purinergic Signalling is Q2 (2024).
The Purinergic Signalling coverage history can be summarized as follows: 2004-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| European Union Politics | journal | 1953 | SAGE Publications Ltd | 79 | 3.71 |
| Proceedings of the ASME Turbo Expo | conference and proceedings | 17577 | 54 | 0.00 | |
| Journal of Business Finance and Accounting | journal | 3244 | Wiley-Blackwell Publishing Ltd | 96 | 3.34 |
| Entrepreneurship Theory and Practice | journal | 168 | SAGE Publications Ltd | 212 | 13.35 |
| Mathematical Modelling and Analysis | journal | 9616 | Vilnius Gediminas Technical University | 31 | 1.49 |
| Child and Family Social Work | journal | 8793 | Wiley-Blackwell Publishing Ltd | 78 | 2.42 |
| Journal, Indian Academy of Clinical Medicine | journal | 28559 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Statistica | journal | 18529 | University of Bologna | 9 | 0.38 |
| Oral Radiology | journal | 9860 | Springer Japan | 28 | 2.17 |
| Journal of Sociology | journal | 6357 | SAGE Publications Ltd | 66 | 2.82 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.92 |
| 2023 | 2.59 |
| 2022 | 2.66 |
| 2021 | 3.27 |
| 2020 | 3.17 |
| 2019 | 2.80 |
| 2018 | 3.13 |
| 2017 | 3.41 |
| 2016 | 3.01 |
| 2015 | 3.30 |
| 2014 | 3.59 |
